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two catalytic (C) subunits (5) , which exist in different isoforms-three for C subunits (a, b, g) and four for R subunits (Ia, Ib, IIa, IIb), each encoded by a separate gene (6) . In addition, protein kinase X can form holoenzymes with R subunits (7) . In the inactive complex, two short linear segments emanating from each R subunit, known as inhibitory sequences, act as substrates [type II regulatory subunit (RII)] or pseudosubstrates [type I regulatory subunit (RI)] that occupy the active site clefts of the C subunits, thus preventing the access of other substrates (5, 8, 9) ; this keeps PKA in the inactive state (5, 8, 9) . Binding of cAMP to two distinct sites on each R subunit induces their dissociation from the C subunits, allowing the C subunits to phosphorylate a large number of PKA substrates located in both the cytosol and the nucleus (5, 8, 9) .
Our group recently discovered that somatic mutations in the gene coding for the Ca subunit of PKA (PRKACA) are responsible for Cushing syndrome owing to cortisolproducing adrenocortical adenomas (CPAs) (10) (11) (12) (13) . This finding has been independently confirmed by other groups (14) (15) (16) (17) (18) . Very recently, rare mutations in the gene coding for the Cb subunit of PKA (PRKACB) were also found in CPAs (19) . Between 23% and 67% of all CPAs carry a recurrent mutation (L206R) of a residue in the Ca subunit that is involved in the interactions with the R subunits (10, 11, (14) (15) (16) . By screening a large group of CPAs we have in the meantime identified six additional PRKACA mutations (199_200insW, S213R+insIILR, 200_201insV, W197R, d2442248+E249Q, and E32V) in unilateral adenomas of patients affected by overt Cushing syndrome (10) (11) (12) . With one exception (E32V), all identified mutations lie in a hot spot region on the surface of the Ca subunit that is adjacent to the active site cleft and faces the R subunit (12) .
Although all previous studies provide strong evidence for a causal role of PRKACA mutations, the mechanisms linking these mutations to increased cell proliferation and cortisol secretion in adrenocortical cells are still debated (10, (14) (15) (16) . One of the initial studies suggested that the L206R mutation increases PKA activity by enhancing substrate interaction and/or the catalytic activity of the enzyme (14) . In contrast, two other studies suggested that the L206R mutation might prevent binding of the R subunit (15, 16) . In strong support of this possibility, we subsequently demonstrated that the two initially identified mutations (L206R and 199_200insW) interfere with the formation of a stable complex with R subunits, thus rendering mutated Ca subunits constitutively active (13) . However, we did not observe increased catalytic activity (13) . Although these data indicate that reduced interaction with R subunits is likely involved in the pathogenesis of Cushing syndrome, at least in the case of the two investigated PRKACA mutations (i.e., L206R and 199_200insW), additional mechanisms might play an equally important role.
Here, we report a comprehensive functional characterization of all PRKACA mutations identified so far. Unexpectedly, our results indicate that in addition to interfering with the binding of R subunits, PRKACA mutations cause major changes in the preference of PKA for its targets, leading to hyperphosphorylation of several PKA substrates, most notably histone H1.4 at Ser36, which is required for and promotes mitosis (20) .
Methods

Plasmids
Plasmids encoding human RIa, RIIb, and RIIb-FLAG were described earlier (13) . A plasmid encoding human wild-type Ca was purchased from Origene. Mutations in the coding sequence of Ca were introduced by PCR as previously described (10) . To generate a plasmid encoding a FLAG-tagged RIa subunit, a fragment containing the entire coding sequence of the human RIa subunit was amplified by PCR with a forward primer containing the FLAG tag (amino acid sequence DYKDDDDA) and a HindIII site at the 5 0 and a reverse primer containing a NotI site at the 3 0 . This fragment was subsequently cloned between the HindIII and NotI sites of pcDNA3.
Tumor tissue
A total of eight snap-frozen tumor specimens from CPAs were investigated. All samples were collected at the University Hospital of Würzburg. Six of these samples were included in previous reports from our group: three in Ronchi et al. (12) and three in Beuschlein et al. (10) . According to our previous sequencing data, four CPA samples harbored somatic PRKACA mutations. In particular, three samples from patients with overt Cushing syndrome presented an L206R substitution and one sample from a patient with mild autonomous cortisol secretion (subclinical Cushing syndrome) presented a d2442 248+E249Q mutation. The four remaining CPAs were PRKACA wild-type. The collection of the clinical data and the biomaterial for this retrospective study was approved by the ethics committee of the University of Würzburg (approvals no. 93/02 and 88/11). Written informed consent was obtained from all patients.
Cell culture and transfection
HEK293A cells were obtained from ATCC. Cells were cultured in DMEM supplemented with 10% fetal calf serum and 0.1 mg/mL streptomycin and 100 U/mL penicillin at 37°C, 5% (v/v) CO 2 . HEK293A cells were seeded at a density of 3.5 3 10 6 cells/15-cm Petri dish, 1.2 3 10 6 cells/10-cm Petri dish, or 0.25 3 10 6 cells per well onto six-well plates and allowed to grow for 24 hours, after which they were transfected with the Effectene transfection kit (Qiagen) according to the manufacturer's protocol. A 1:8 ratio of transfected C and R subunit DNAs was used to favor association between C and R subunits (10) . All experiments were performed 48 hours after transfection. For stable isotope labeling with amino acids in cell culture (SILAC), the cells were grown in light (Lys0, Arg0) or heavy (Lys8, Arg10) labeled DMEM supplemented with 10% dialyzed fetal calf serum and 0.1 mg/mL streptomycin and 100 U/mL penicillin for at least six passages before the experiment.
Preparation of cell lysates
Cells were washed with ice-cold PBS, scraped off plates, and resuspended in 300 mL 5/2 buffer (5 mM Tris-HCl, 2 mM EDTA; pH, 7.4). Thereafter, samples were homogenized using an Ultra-Turrax device for 20 seconds on ice and centrifuged at 50,000g for 30 minutes at 4°C to remove membranes.
Preparation of total cell lysates
Cells were washed once with PBS. Next, 2 mL of lysis buffer (8 M urea, 1 mM sodium vanadate, 2.5 mM pyrophosphate, 1 mM b-glycerophosphate, 20 mM HEPES; pH, 8.0) supplemented with cOmplete, Mini, EDTA-free Protease Inhibitor Cocktail (Roche) was added to each 15-cm Petri dish, and the cells were scraped into the buffer. Cell suspensions were sonicated three times for 15 seconds each, and lysates were cleared by centrifugation at 4000 rpm for 1 hour at 15°C.
PKA activity assay
PKA catalytic activity was measured on cell lysates using the PepTag nonradioactive cAMP-dependent protein kinase assay (Promega), which uses fluorescent kemptide as a substrate, following the manufacturer's instructions. Images of the gels were acquired with a gel documentation system (Hero Lab) and analyzed using ImageJ software (http://rsbweb.nih.gov/ij). Endogenous PKA activity was subtracted, and values were normalized to the value of the stimulated wild-type.
Coimmunoprecipitation
Cells were lysed with a buffer containing 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 20 mM Tris-HCl, pH 7.5, supplemented with cOmplete Mini Protease Inhibitor Cocktail (Roche). Lysates were centrifuged at 20,000g for 10 minutes at 4°C. Supernatants were transferred to a new vial and incubated with protein A-sepharose for 2 hours at 4°C under continuous rotation. Protein A-sepharose was preincubated with a mouse monoclonal anti-FLAG antibody [#F3165, RRID: AB_259529; Sigma-Aldrich (21)]. Preincubations were performed overnight at 4°C under continuous rotation. After the incubation of protein A-sepharose with the cell lysates, samples were washed five times with lysis buffer. Proteins were recovered from protein A-sepharose by the addition of Laemmli buffer, followed by incubation at 95°C for 3 minutes. After Western blot analysis and quantification, the amount of Ca was normalized to that in the wild-type sample.
Histone extraction
Histones were acid-extracted from cells and CPA samples as described by Shechter et al. (22) . Briefly, harvested cells or Dounce-homogenized tissue samples were lysed in a hypotonic lysis buffer (150 mM Tris/HCl, 1 mM KCl, 1.5 mM MgCl 2 , 1 mM DTT; pH, 8.0) supplemented with 0.5 mg/mL leupeptin, 2 mg/mL aprotinin, 0.1 mM phenylmethylsulfonyl fluoride, cOmplete Mini Protease Inhibitor Cocktail (Roche), and a phosphatase inhibitor cocktail (Roche). Lysates were then acid-extracted with H 2 SO 4 for 30 minutes followed by precipitation with trichloroacetic acid and resuspension in H 2 O.
Western blot analysis
Samples were mixed with Laemmli buffer and incubated at 95°C for 3 minutes. Proteins were separated by electrophoresis on either a 10% or a 15% (for histone H1.4) SDS polyacrylamide gel and electro-transferred to a polyvinylidene difluoride membrane (Merck Millipore). Membranes were blocked with Tris-buffered saline supplemented with 1% Tween and 5% skim milk powder or bovine serum albumin (antibodies detecting phosphoproteins) for 1 hour at room temperature and incubated overnight at 4°C with the indicated primary antibody, followed by incubation with horseradish peroxidase-conjugated secondary antibodies for 1 hour at room temperature. PKA Ca subunits were detected with a rabbit polyclonal antibody [#4782, 1:7000 dilution, RRID: AB_2170170; Cell Signaling (23)]. FLAG-tagged R subunits were detected using a rabbit monoclonal anti-FLAG antibody [#F7425, 1:4000 dilution, RRID: AB_439687; Sigma-Aldrich 
Substrate specificity of PKA Ca mutants in silico
The in silico prediction was done using the Kinase Substrate Prediction version 2.0 algorithm (30) . This algorithm predicts substrate specificity on the basis of the primary amino acid sequence of more than 488 human protein kinase catalytic domains and 10,000 known kinase2substrate phosphosite pairs. The algorithm computes a specificity matrix for a given kinase or mutant thereof, wherein values indicate the relative preference for each amino acid at each position around the phosphoacceptor site. Only relevant changes are reported.
Substrate specificity of PKA Ca mutants in vitro
Mutant and wild-type samples were labeled with heavy and light amino acids as described in cell culture and transfection. Before total cell lysates were prepared, the cells were stimulated with 10 mM forskolin for 30 minutes. Protein concentration of the total cell lysates was determined using the bicinchoninic acid assay. Before the samples were processed for phosphoproteomics, an input sample for proteome analysis was taken, which was digested with trypsin and analyzed by nanoscale liquid chromatography coupled to tandem mass spectrometry (nano LC-MS/MS). For phosphoproteomics experiments, no more than 20 mg of protein were used. Substrate specificity was assessed using the PTMScan Phospho-PKA Substrate Motif (RRXS*/T*) Kit [#5565, RRID: AB_2756464; Cell Signaling (31)] following manufacturer's instructions; see the online repository (32) for details. The dried peptides were stored at 220°C until the nano LC-MS/MS analyses.
Nano LC-MS/MS analyses
Nano LC-MS/MS analyses were performed on an Orbitrap Fusion system (Thermo Fisher Scientific) equipped with an EASY-Spray Ion Source and coupled to an EASY-nLC 1000 (Thermo Fisher Scientific). Peptides resuspended in 2% acetonitrile and 0.1% formic acid were loaded on a trapping column (2 cm 3 75 mm ID, PepMap C18, 3-mm particles, 100Å pore size) and separated on an EASY-Spray column (50 cm 3 75 mm ID, PepMap C18, 2-mm particles, 100Å pore size) with a 140-minute linear gradient from 3% to 45% acetonitrile and 0.1% formic acid.
Both mass spectrometry (MS) and tandem mass spectrometry (MS/MS) scans were acquired on the Orbitrap analyzer with a resolution of 60,000 for MS scans and 15,000 for MS/ MS scans. Higher-energy collisional dissociation fragmentation with 35% normalized collision energy was applied. A top-speed data-dependent MS/MS method with a fixed cycle time of 3 seconds was used. Dynamic exclusion was applied with a repeat count of 1 and an exclusion duration of 60 seconds; singly charged precursors were excluded from selection. Minimum signal threshold for precursor selection was set to 5 3 10 4 . Predictive automatic gain control was used with target values of 2 3 10 5 for MS scans and 5 3 10 4 for MS/MS scans. EASY-IC was used for internal calibration.
Raw data processing and database search
For raw data processing, database searches, and SILAC quantification, MaxQuant software version 1.5.6.5 was used (33) . The search was performed against the human UniProt reference proteome database (download date: 9 December 2016) plus a small database containing known immunoglobulin chains. In addition, a database containing common contaminants (included in MaxQuant) was used. The search was performed with tryptic cleavage specificity and three allowed miscleavages. Results were filtered to a false discovery rate ,1% on protein, peptide, and phosphosite levels, and for modified peptides, a minimum score of 40 and a minimum delta score of 6 were required. In addition to default settings, protein N-terminal acetylation, Gln to pyro-Glu formation, oxidation, and phosphorylation were included as variable modifications; carbamidomethyl was set as fixed modification. For SILAC quantification, light (Arg0/Lys0) and heavy (Arg10/Lys8) labeling were selected, with a maximum of four labeled amino acids per peptide allowed; matching between runs was disabled.
For further data analysis in R, the MaxQuant "Phospho Sites" table was processed, and only phosphosites with a localization probability .0.75 and a posterior error probability ,0.05 were included. For each experiment, the distribution of log 2 -transformed heavy/light SILAC ratios was normalized to the first mode of the distribution. Data from replicate experiments were combined, and Student t test as well as limma P values were calculated and corrected for multiple-hypothesis testing (Benjamini-Hochberg algorithm, false discovery rate). In addition, boxplot outliers with values outside the 1.53 and/or the 33 interquartile range of the first or third quartile were labeled as significant or highly significant only if a replicate notch, defined as 1.58*interquartile range/sqrt(number of experiments), was not overlapping with the median of all such notches.
Motif logo
For calculation of position weight matrices from the phosphoproteomics data, the Web tool plogo (http://plogo.uconn. edu/) (34) was used. Values were calculated relative to the background amino acid frequencies in the human proteome. Motif logos were then generated using WebLogo software version 3.5.0 (35) .
Structures
Protein structures were generated using PyMOL version 1.7.4.5. The protein data bank entries 3TNP (9) and 3TNQ (9) were used as templates for the structures of the PKA Ca-RIIb holoenzyme and the Ca subunit in complex with a phosphorylated substrate, respectively.
Statistical analyses
Statistical analyses were performed using Prism 6 software (GraphPad). Values are given as mean 6 SEM. Differences between two groups were assessed by the two-tailed Student t test. Differences among three or more groups were assessed by two-way ANOVA, followed by the Bonferroni post hoc test. Differences were considered significant for P values ,0.05.
Results
PRKACA mutations had variable effects on R subunit binding
Through genetic screening of a large series of CPAs from patients with Cushing syndrome, we identified a total of seven PRKACA mutations, including the most frequent L206R, with an overall prevalence in CPAs of ;40% (10) (11) (12) . The results of all available studies to date are summarized in Table 1 . With the exception of E32V, all mutations identified so far lie at a hot spot at the interface with the R subunit ( Fig. 1 ). Because our previous data indicated that the two initially identified mutations (L206R and 199_200insW) interfered with 
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the formation of a stable complex with the inhibitory RIIb subunit (13), we first evaluated the interaction of all mutations identified so far with both RIa and RIIb-the two main R subunit isoforms expressed in adrenocortical cells-by coimmunoprecipitation [ Fig. 2 and (32) ].
As expected, we observed a robust coimmunoprecipitation of exogenously expressed wild-type Ca with both RIa and RIIb [ Fig. 2 and (32) ]. In the case of four mutants (199_200insW, L206R, 200_201_insV, and S213R+insIILR), we detected only faint signals in the presence of either RIa or RIIb, indicating that the interaction with both R subunit isoforms was largely lost, consistent with our previous observations (13) . Unexpectedly, however, two mutants (W197R and E32V) displayed normal binding to both RIa and RIIb (Fig. 2,  arrows) . Of note, a previous report indicated that the W197R mutant cannot bind to R subunits unless they are stripped off of cAMP, a condition that is not occurring in intact cells (36) . The d2442248+E249Q mutant had an interesting behavior, as it showed normal binding to RIIb but a complete lack of binding to RIa (Fig. 2, arrow) . With the exception of S213R+insIILR, all Ca mutants dissociated virtually completely from R subunits upon addition of cAMP [ Fig. 2 and (32) ].
PRKACA mutations had variable effects on PKA activity
Next, we investigated the activity of the Ca mutants against the widely used synthetic peptide substrate kemptide.
In lysates obtained from HEK293A cells cotransfected with wild-type or mutant Ca subunits and either RIa or RIIb, we observed high variability among the investigated Ca mutants. A first group of mutants (199_200insW, L206R, W197R, d2442248+E249Q, and S213R+insIILR) were characterized by increased basal activity against kemptide in at least one condition (i.e., with RIa or RIIb) (Fig. 3) . The E32V mutant was apparently behaving like wild-type Ca (Fig. 3 ). The 200_201insV mutant was characterized by strongly reduced maximal activity (measured in the presence of cAMP) against kemptide compared with wild-type Ca (Fig. 3) .
Unexpectedly, a different picture was observed when PKA activity was evaluated against endogenous substrates in lysates of HEK293A cells transfected with the different Ca mutants and analyzed by Western blot analysis with an antiphospho-PKA substrate antibody (32) . In this assay, RIIb but not RIa coexpression was capable of buffering the activity of exogenous wild-type or mutant Ca subunits, consistent with previous observations (9) . Therefore, we focused on the results obtained in the presence of RIIb. In cells cotransfected with RIIb, two Ca mutants (199_200insW and L206R) showed strongly increased basal activity compared with wildtype Ca (32) . The remaining mutants were characterized by a variable degree of increased basal activity compared with wild-type Ca (32) . Notably, in this assay, the 200_ 201insV mutant, which was characterized by strongly reduced maximal activity in the kemptide assay, could be stimulated by addition of the adenylyl cyclase activator forskolin to a similar although slightly lower extent compared with wild-type Ca (32) . At a closer look, this analysis also revealed potentially different phosphorylation patterns for the Ca mutants compared with the wild-type Ca as well as among the Ca mutants (32) . Altogether, these data suggest the possibility that the investigated PRKACA mutations may alter the relative preference of PKA for its substrates so that investigation of a single synthetic substrate does not provide a satisfactory description of the activity of Ca mutants against endogenous substrates.
In silico analysis of PRKACA mutations predicted changes in substrate specificity
Our results suggest the possibility that PRKACA mutations may alter the preference of PKA for its substrates, thus causing a relative change in substrate specificity. This hypothesis is consistent with the location of most PRKACA mutations in a region of Ca that is critical for substrate binding and recognition (36, 37) ( Fig. 1B) . To further explore this possibility, we performed an in silico analysis using a protein kinase substrate prediction algorithm (30) . The algorithm predicted relevant changes in substrate specificity for four mutants: 199_200insW, L206R, d2442248+E249Q, and 200_ 201insV [ Fig. 1B and (32) ]. The largest change was predicted for the d2442248+E249Q mutant. For the S213R+insIILR mutant, the algorithm predicted only minor effects on substrate specificity, whereas no changes were predicted for the two remaining mutants (E32V, W197R).
Phosphoproteomics revealed major changes in substrate specificity caused by PRKACA mutations
Motivated by the results of the Western blot analysis and the in silico prediction, we used a quantitative phosphoproteomics approach to comprehensively analyze and quantitatively compare the substrate repertoires of wild-type and mutant PKA Ca in mammalian cells. Fig. 1 and an online repository (32) .
The three PKA Ca mutations predicted to have the largest effects on substrate specificity were analyzed (Fig. 4) . These were the frequent L206R mutation, the d2442248+E249Q mutation, which was predicted to have the strongest effect on substrate specificity, and the 200_201insV mutation, which shared prediction with the adjacent 199_200insW mutation. All cell lysates were obtained after 30-minute stimulation with the adenylyl cyclase activator forskolin to allow comparison under conditions of maximal PKA activity. The phosphoproteomics analysis identified 463 sites phosphorylated by the wild-type Ca subunit. A direct quantitative comparison between wild-type and mutant Ca subunits demonstrated that the investigated PRKACA mutations caused major changes in the pattern of PKA substrate phosphorylation (Fig. 4) . These changes involved 62, 116, and 75 substrates that were either hyperphosphorylated or hypophosphorylated by the L206R, d2442248+E249Q, and 200_201insV mutants, respectively, compared with the wild-type [ Fig. 4 and (32) ].
Our data also allowed us to compute sequence logos of the region encompassing the phosphoacceptor site, where the size of the letters, each corresponding to a given amino acid, indicates their relative frequency at a given position ( Fig. 4) . Overall, the analysis showed relevant changes in the preferred amino acids surrounding the RR/KXpS/T phosphorylation consensus sequence, including an increased preference for amino acids with small or hydrophobic, nonaromatic side chains (glycine, alanine, valine, methionine) at position +1 from the phosphoacceptor site, at the expense of phenylalanine and other amino acids (Fig. 4) . Moreover, we observed an increased preference for leucine at position +1 from the phosphoacceptor site and an increased preference for acidic residues in the residues downstream of the phosphoacceptor site for the L206R mutant, consistent with a recent report by Lubner et al. (38) in Escherichia coli. In addition, the L206R mutant was characterized by a loss of preference for arginine residues at positions 27 to 24 relative to the phosphoacceptor site and an increased preference for glutamic acid and serine at several positions. For the d2442248+E249Q mutant, we found an increased preference for leucine at position 21 from the phosphoacceptor site and a reduced PRKACA mutations affect substrate specificity as revealed by phosphoproteomics analysis. HEK293A cells were cotransfected with RIIb and either wild-type (WT) or mutant Ca subunits and labeled with light amino acids (WT) or heavy amino acids (mutant). Protein lysates from these cells were then proteolytically fragmented, and the resulting phosphopeptides were immunoprecipitated (IP) using a phospho-PKA substrate antibody recognizing the RR/KXpS/T consensus. Phosphopeptides (here P indicates the attached phosphate group) were separated and detected by nano LC-MS/MS. Scatter plots show the abundance of the detected phosphopeptides in the mutant relative to WT samples of three independent experiments. Phosphopeptides that are significantly preferred by the mutant or the WT are colored; phosphopeptides that show no significant difference (ns) between WT and mutant are depicted in gray. The sequence logos report for each mutant the relative amino acid preferences around the consensus motif (RR/KXpS/T) for both hypophosphorylated (left) and hyperphosphorylated (right) sequences, calculated from the phosphopeptides. Values are expressed as log 10 -odds of the significance of overrepresentation vs the significance of underrepresentation, which is calculated using the binomial probability of residue frequencies.
preference for acidic residues downstream of the phosphoacceptor site. The latter trend was mirrored in the hypophosphorylated peptides, where acidic residues were overrepresented downstream of the phosphoacceptor site. Interestingly, both mutants (L206R and d2442248+E249Q) showed an asymmetric effect on substrate phosphorylation, with a higher number of peptides that were hyperphosphorylated (40 and 93, respectively) compared with a relatively lower number of hypophosphorylated ones (22 and 23, respectively). Therefore, both mutations seemed to increase mainly the phosphorylation of poor substrates of the wild-type enzyme, while causing only smaller decreases in the phosphorylation of other substrates.
For the 200_201insV mutant, we observed an increased preference for leucine and alanine at position 21, accompanied by a loss of preference for acidic residues downstream of the phosphoacceptor site and an increased preference for proline at position +3. The loss of preference for peptides containing acidic residues at downstream positions was reflected by their relative overrepresentation in the corresponding hypophosphorylated peptides (Fig. 4, left panel) . In contrast to the other two mutants, the 200_201insV mutant was characterized by a rather symmetric distribution with 35 hypophosphorylated and 40 hyperphosphorylated peptides, suggesting that comparable numbers of substrates were either hyperphosphorylated or hypophosphorylated. In general, the phosphorylation patterns differed among the three Ca mutants. However, four substrates were consistently found to be hyperphosphorylated by all three mutants compared with the wild-type. These were the citron rho-interacting kinase (CIT; Ser 480), the mitochondrial import receptor subunit TOM34 (Ser 93), histone H1.2 (Ser 36), and histone H1.4 (Ser 36) ( Fig. 4) . H1.2, H1.4, TOM34, and CIT were also found to be present and phosphorylated at the same sites in lysates of the cortisol-producing adrenocortical cell line NCI-H295R (32) .
To rule out the possibility that the observed changes were due to changes in protein levels rather than phosphorylation, we performed an additional proteomics experiment on the same cell lysates that allowed us to directly compare the relative amounts of proteins at the proteome level between wild-type and mutant samples, including, importantly, H1.2, H1.4, and TOMM34 (32) .
The results indicate that the levels of most proteins, including H1.2, H1.4, and TOMM34, were unchanged between wild-type and mutant samples.
Although hyperphosphorylation of CIT and TOM34 may mediate some effects of PRKACA mutations, we concentrated our attention on H1 because phosphorylation by PKA of histone H1.4 on Ser36-and possibly of the highly homologous Ser36 site on H1.2-is required for mitosis (20) .
PRKACA mutations caused histone H1.4 hyperphosphorylation in vitro and in CPAs
The conserved Ser36 phosphorylation site on histone H1 isoforms has been implicated in chromatin condensation and mitosis (20) . This has been better studied for histone H1.4, which was shown to be phosphorylated by PKA on Ser36 during mitosis, an event that induced histone H1.4 dissociation from chromatin and was required for mitosis (20) . Because of the potential relevance of histone H1 Ser36 phosphorylation for the mechanism of action of PRKACA mutations, we first investigated histone H1.4 phosphorylation in HEK293A cells transfected with Ca subunit mutants. In HEK293A cells, overexpression of the L206R mutant caused a strong increase (12-fold under basal conditions; threefold in the presence of forskolin) in histone H1.4 Ser36 phosphorylation compared with overexpression of wild-type Ca [ Fig. 5 and (32)]. Modestly increased levels of histone H1.4 Ser36 phosphorylation were also observed with the d2442248+E249Q and 200_201insV mutants compared with wild-type Ca, even though these differences did not reach statistical significance [ Fig. 5 and (32) ].
Furthermore, we analyzed histone H1.4 Ser36 phosphorylation in human CPA tumor samples of patients with Cushing syndrome with or without PRKACA mutations (32) . Of note, a ninefold increase in histone H1.4 Ser36 phosphorylation was observed in CPAs carrying the L206R mutation compared with CPAs without PRKACA mutations (1.9 6 0.26 vs 0.21 6 0.29; P = 0.009) (Fig. 6 ). These results indicated that in patients with adrenal Cushing syndrome, at least the by far most frequent L206R mutation is associated with a strong increase of H1.4 phosphorylation in patients' tumor tissue.
Discussion
Our results indicate that PRKACA mutations found in CPAs alter PKA preference for its targets, inducing hyperphosphorylation of several PKA substrates; most notably, this includes histone H1.4 at Ser36, which has been suggested to have an essential role in mitosis (20) . Thus, our study revealed another key mechanism that, together with increased PKA basal activity, may explain the development of CPAs in the presence of somatic PRKACA mutations (32) .
Although our previous study on the two PRKACA mutations initially identified in adrenal Cushing syndrome (L206R and 199_200insW) showed that they increased basal PKA activity by preventing the binding of R subunits, the present results obtained on a larger group of PRKACA mutations indicate that this is not always the case [see an online repository (32) for a summary of the present results] and that a relative change in PKA substrate specificity likely contributes to the mechanism of action of PRKACA mutations.
Our phosphoproteomics analysis revealed four PKA substrates that were hyperphosphorylated by all three PKA Ca mutants analyzed and are thus potentially involved in the pathogenesis of CPAs due to PRKACA mutations. These are CIT (Ser 480), TOM34 (Ser 93), histone H1.2 (Ser 36), and histone H1.4 (Ser 36). Of note, all four substrates were also shown to be expressed and phosphorylated on the same sites in lysates of NCI-H295R cells, which are widely used as a model of differentiated, cortisol-producing adrenocortical cells (32) . Of these, histone H1.4 and the highly homologous histone H1.2 appeared particularly intriguing because H1 histones play an important role in promoting, regulating, and maintaining chromatin organization and thus are deeply involved in the regulation of gene transcription and mitosis (20, (39) (40) (41) . H1 histones possess a conserved serine residue at position 36 (Ser36), which has been Figure 6 . Effect of PRKACA mutations on histone H1.4 phosphorylation in tumor (CPA) samples from patients with adrenal Cushing syndrome. Histones were extracted from CPAs with or without PRKACA mutations and analyzed by Western blot analysis with an antibody specifically recognizing H1.4 phosphorylated at Ser36. A Western blot analysis for total histone H1.4 was used as a loading control. Western blot images were quantified by densitometric analysis. Quantified data are mean 6 SEM of three and four CPAs carrying the L206R mutation or with PRKACA wild-type (WT), respectively. Triangles and dots represent individual replicates. Differences are statistically significant by unpaired t test (**P = 0.009). investigated mainly for histone H1.4. Interestingly, histone H1.4 has been shown to be strongly phosphorylated on Ser36 by PKA at the first stage of mitosis (prophase), then rapidly reverting to normal low phosphorylation levels during cytokinesis (20) . Phosphorylation of histone H1.4 on Ser36 has been shown to promote histone H1.4 dissociation from mitogenic DNA and induce changes in chromatin organization (20) . Moreover, it has been shown that silencing H1.4 inhibits mitosis, an effect that cannot be rescued by a phosphorylation-deficient H1.4 mutant (S36A) (20) . These findings indicate that the PKA-dependent phosphorylation of histone H1.4 at Ser36 plays an important role in promoting mitosis, presumably by inducing changes in chromatin structure that are required for the realization of the mitogenic program (20) .
Although other changes in the PKA phosphorylation pattern caused by PRKACA mutations may also play a role in the pathogenesis of CPAs, it is noteworthy that two of the four hyperphosphorylated sites shared by the three tested Ca mutants are Ser36 on histone H1.4 and the corresponding Ser36 on histone H1.2, which likely plays a similar role. Our finding that histone H1.4 is highly hyperphosphorylated in CPAs carrying the L206R mutation-but not in those with wild-type PKA-supports the role of H1.4 hyperphosphorylation in the pathogenesis of CPAs due to PRKACA mutations. Further investigations, such as studies on chromatin organization by 4 0 ,6diamidino-2-phenylindole staining and H1.4-chromatin association by immunofluorescence (20) or chromatin immunoprecipitation are required to further clarify the effect of increased H1.4 (Ser36) phosphorylation on chromatin organization in PRKACA-mutated CPA tissue.
In addition to hyperphosphorylation of histone H1, that of CIT and of TOM34-which, to the best of our knowledge, were not previously reported to be phosphorylated by PKA-may also play a role in the mechanism of action of PRKACA mutations. CIT is a serine/ threonine protein kinase shown to be required for cytokinesis (42) . Phosphorylation of Ser480 may potentially influence the activity of CIT and thus affect cytokinesis. TOM34 is involved in mitochondrial protein import (43) . Interestingly, yeast TOM70 has been phosphorylated by PKA on Ser174 (44) , which is homologous to Ser93 in human TOM34. In yeast, TOM70 phosphorylation by PKA inhibits its receptor activity, which results in reduced mitochondrial import of metabolite carriers (44) . Phosphorylation of TOM34 at Ser93 could have a similar effect. Future studies are required to evaluate the role of CIT and TOM34 in the pathogenesis of CPAs.
The finding that PRKACA mutations cause histone H1.4 phosphorylation may help explain why these mutations lead to the development of CPAs, whereas normal cAMP/PKA signaling, such as that resulting from physiological stimulation by ACTH, has no or at most only mild proliferative effects on adrenocortical cells (45, 46) . Intriguingly, this may suggest that although an increase in PKA activity can induce excess cortisol production in the presence of PRKACA mutations, a change in PKA substrate preference-and the resulting hyperphosphorylation of histone H1.4 and possibly other targets involved in the control of cell replication-may be required to stimulate cell proliferation.
Finally, our findings indicate that given the important changes in substrate specificity caused by PRKACA mutations, it may be possible to develop selective orthosteric PKA inhibitors that bind only to the mutant Ca subunits and thus selectively inhibit the mutated PKA in CPAs without affecting the function of wild-type PKA in normal cells.
In summary, our findings indicate that PRKACA mutations found in CPAs led to a change in the pattern of PKA phosphorylation that may play an important role in their mechanism of action. This not only reveals a key mechanism potentially involved in the pathogenesis of CPAs and Cushing syndrome but also may allow the development of selective PKA inhibitors for therapeutic purposes that block mutated but not wild-type PKA. Moreover, these findings provide a highly illustrative example of how mutations altering substrate specificity of a protein kinase may cause human disease, which may have implications for other conditions. Dental Sciences, Edgbaston, B15 2TT Birmingham, United Kingdom. E-mail: D.Calebiro@bham.ac.uk.
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